EUVIMEDEUVIMED entdecken
Crossref

Bioorthogonal-Activated In Situ Vaccine Mediated by a COF-Based Catalytic Platform for Potent Cancer Immunotherapy

Mengyu Sun, Zhengwei Liu, Li Wu, Jie Yang, Jinsong Ren iD, Xiaogang Qu iD

Journal of the American Chemical Society · 2023

DOI: 10.1021/jacs.2c13010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2023. Verfasst von Mengyu Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: Cancer Vaccines, Metal-Organic Frameworks, Neoplasms. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Excellent Youth Foundation of Jiangsu Scientific Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesMetal-Organic FrameworksNeoplasmsHumansDoxorubicinImiquimodAdjuvants, ImmunologicImmunotherapyCell Line, Tumor

Substanzen

Cancer VaccinesMetal-Organic FrameworksDoxorubicinImiquimodAdjuvants, Immunologic

Autor:innen und Institutionen

  • Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, Jilin, P. R. China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, Anhui, P. R. China.
  • Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, Nantong 226019, Jiangsu, P. R. China.

ORCID-Profile: Jinsong Ren, Xiaogang Qu

Förderung

  • Excellent Youth Foundation of Jiangsu Scientific Committee

Zitieren

APA

Sun, M., Liu, Z., Wu, L., Yang, J., Ren, J., & Qu, X. (2023). Bioorthogonal-Activated In Situ Vaccine Mediated by a COF-Based Catalytic Platform for Potent Cancer Immunotherapy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.2c13010

Vancouver

Sun M, Liu Z, Wu L, Yang J, Ren J, Qu X. Bioorthogonal-Activated In Situ Vaccine Mediated by a COF-Based Catalytic Platform for Potent Cancer Immunotherapy. Journal of the American Chemical Society. 2023. doi:10.1021/jacs.2c13010

BibTeX
@article{Sun2023,
  author = {Sun, Mengyu and Liu, Zhengwei and Wu, Li and Yang, Jie and Ren, Jinsong and Qu, Xiaogang},
  title = {Bioorthogonal-Activated In Situ Vaccine Mediated by a COF-Based Catalytic Platform for Potent Cancer Immunotherapy},
  journal = {Journal of the American Chemical Society},
  year = {2023},
  doi = {10.1021/jacs.2c13010}
}
Kostenlos starten →